Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 744

1.

[Clinical significance of RYBP expression in primary hepatocellular carcinoma].

Jing X, Cai W, Huang B, Chen H, Chen D.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 Apr 28;44(4):399-405. doi: 10.11817/j.issn.1672-7347.2019.04.009. Chinese.

2.

Zygomatic bone metastasis from hepatocellular carcinoma and the therapeutic efficacy of apatinib: A case report and literature review.

Lei Q, Chen H, Zheng H, Deng F, Wang F, Li J, Hu J, Fu R, Zhen Z.

Medicine (Baltimore). 2019 May;98(18):e14595. doi: 10.1097/MD.0000000000014595. Review.

3.

MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.

Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H.

Life Sci. 2019 May 1;224:1-11. doi: 10.1016/j.lfs.2019.03.028. Epub 2019 Mar 12.

PMID:
30876939
4.

[Conventional serum tumor markers in liver cancer. Retrospective analysis of 118 patients].

Arias-Flórez JS, Martínez-Delgado AM, Alarcón-Tarazona ML, Insuasty-Enriquez JS, Díaz-Martínez LA.

Rev Med Chil. 2018 Dec;146(12):1422-1428. doi: 10.4067/s0034-98872018001201422. Spanish.

5.

Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.

Abdel-Rahman O, Cheung WY.

Med Oncol. 2019 Feb 1;36(3):26. doi: 10.1007/s12032-019-1248-2.

PMID:
30707324
6.

Hepatoid Variant of Yolk Sac Tumor of Both Ovaries with Widespread Intraabdominal and Lung Metastasis: A Case Report.

Parampalli Srinivas S, Shivamurthy A, Rao L, Gurumoorthy Bhat R.

Iran J Pathol. 2018 Spring;13(2):289-293. Epub 2018 Jul 17.

7.

Metastatic cardiac tumors: literature review and own observation of testicular tumor metastasis in the right ventricle of the heart.

Zakhartseva LM, Zakharova VP, Shatrova KM, Chitaeva GE, Vitovsky RM.

Exp Oncol. 2018 Dec;40(4):336-342. Review.

PMID:
30593757
8.

Expression of TBX3 in Hepatocellular Carcinoma and Its Clinical Implication.

Li Z, Wang Y, Duan S, Shi Y, Li S, Zhang X, Ren J.

Med Sci Monit. 2018 Dec 22;24:9324-9333. doi: 10.12659/MSM.909378.

9.

Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma.

Zhu X, Qi G, Li C, Bei C, Tan C, Zhang Y, Shi W, Zeng W, Kong J, Fu Y, Tan S.

DNA Cell Biol. 2019 Feb;38(2):193-197. doi: 10.1089/dna.2018.4513. Epub 2018 Dec 18.

PMID:
30562063
10.

Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases.

Chen D, Li Z, Song Q, Qian L, Xie B, Zhu J.

Medicine (Baltimore). 2018 Dec;97(50):e13356. doi: 10.1097/MD.0000000000013356.

11.

Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Zeng XY, Yin YP, Xiao H, Zhang P, He J, Liu WZ, Gao JB, Shuai XM, Wang GB, Wu XL, Tao KX.

Curr Med Sci. 2018 Dec;38(6):1054-1061. doi: 10.1007/s11596-018-1983-1. Epub 2018 Dec 7.

PMID:
30536069
12.

SMARCB1/INI1 Is Diagnostically Useful in Distinguishing α-Fetoprotein-producing Gastric Carcinoma from Hepatocellular Carcinoma.

Mochizuki K, Kawai M, Odate T, Tahara I, Inoue T, Kasai K, Nakazawa T, Kondo T.

Anticancer Res. 2018 Dec;38(12):6865-6868. doi: 10.21873/anticanres.13061.

PMID:
30504402
13.

Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.

Huang J, Wang X, Zhu Y, Wang Z, Li J, Xu D, Wang S, Li TE, Lu L.

J Surg Oncol. 2019 Jan;119(1):40-46. doi: 10.1002/jso.25303. Epub 2018 Nov 27.

PMID:
30480811
14.

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.

Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3130. doi: 10.3390/ijms19103130.

15.

A case of giant panda ovarian cancer diagnosis and histopathology.

Gao Q, Wang C, Li D, Zhang H, Deng L, Li C, Chen Z.

BMC Vet Res. 2018 Oct 12;14(1):311. doi: 10.1186/s12917-018-1630-x.

16.

The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies.

Wang Z, Wang J, Wang P.

PLoS One. 2018 Oct 12;13(10):e0202987. doi: 10.1371/journal.pone.0202987. eCollection 2018.

17.

[Efficacy and safety of licartin with repeated administration in treatment of HCC patients after liver transplantation].

Li J, Qin L, Ding EC, Shen J, Li JP.

Zhonghua Yi Xue Za Zhi. 2018 Sep 4;98(33):2645-2649. doi: 10.3760/cma.j.issn.0376-2491.2018.33.007. Chinese.

PMID:
30220152
18.

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.

Li J, Han X, Yu X, Xu Z, Yang G, Liu B, Xiu P.

J Exp Clin Cancer Res. 2018 Sep 3;37(1):213. doi: 10.1186/s13046-018-0893-1. Review.

19.

Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer.

Yang Y, Qin Z, Du D, Wu Y, Qiu S, Mu F, Xu K, Chen J.

Cardiovasc Intervent Radiol. 2019 Jan;42(1):48-59. doi: 10.1007/s00270-018-2069-y. Epub 2018 Aug 27.

20.

Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.

Yin LC, Luo ZC, Gao YX, Li Y, Peng Q, Gao Y.

Biomed Res Int. 2018 Jun 26;2018:3789613. doi: 10.1155/2018/3789613. eCollection 2018.

Supplemental Content

Loading ...
Support Center